Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations

Judith A. Seidel(Kyoto University), Kenji Kabashima(Agency for Science, Technology and Research)
Frontiers in Oncology
March 28, 2018
Cited by 1,331


Related Papers